Please use this identifier to cite or link to this item:
https://doi.org/10.1371/journal.pone.0036115
DC Field | Value | |
---|---|---|
dc.title | Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers | |
dc.contributor.author | Yiu K.H. | |
dc.contributor.author | Atsma D.E. | |
dc.contributor.author | Delgado V. | |
dc.contributor.author | Ng A.C.T. | |
dc.contributor.author | Witkowski T.G. | |
dc.contributor.author | Ewe S.H. | |
dc.contributor.author | Auger D. | |
dc.contributor.author | Holman E.R. | |
dc.contributor.author | van Mil A.M. | |
dc.contributor.author | Breuning M.H. | |
dc.contributor.author | Tse H.F. | |
dc.contributor.author | Bax J.J. | |
dc.contributor.author | Schalij M.J. | |
dc.contributor.author | Marsan N.A. | |
dc.date.accessioned | 2019-11-11T06:39:48Z | |
dc.date.available | 2019-11-11T06:39:48Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | Yiu K.H., Atsma D.E., Delgado V., Ng A.C.T., Witkowski T.G., Ewe S.H., Auger D., Holman E.R., van Mil A.M., Breuning M.H., Tse H.F., Bax J.J., Schalij M.J., Marsan N.A. (2012). Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers. PLoS ONE 7 (5) : e36115. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0036115 | |
dc.identifier.issn | 19326203 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/161984 | |
dc.description.abstract | Background: To evaluate the presence of myocardial structural alterations and subtle myocardial dysfunction during familial screening in asymptomatic mutation carriers without hypertrophic cardiomyopathy (HCM) phenotype. Methods and Findings: Sixteen HCM families with pathogenic mutation were studied and 46 patients with phenotype expression (Mut+/Phen+) and 47 patients without phenotype expression (Mut+/Phen-) were observed. Twenty-five control subjects, matched with the Mut+/Phen- group, were recruited for comparison. Echocardiography was performed to evaluate conventional parameters, myocardial structural alteration by calibrated integrated backscatter (cIBS) and global and segmental longitudinal strain by speckle tracking analysis. All 3 groups had similar left ventricular dimensions and ejection fraction. Basal anteroseptal cIBS was the highest in Mut+/Phen+ patients (-14.0±4.6 dB, p<0.01) and was higher in Mut+/Phen- patients as compared to controls (-17.0±2.3 vs. -22.6±2.9 dB, p<0.01) suggesting significant myocardial structural alterations. Global and basal anteroseptal longitudinal strains (-8.4±4.0%, p<0.01) were the most impaired in Mut+/Phen+ patients as compared to the other 2 groups. Although global longitudinal strain was similar between Mut+/Phen- group and controls, basal anteroseptal strain was lower in Mut+/Phen- patients (-14.1±3.8%, p<0.01) as compared to controls (-19.9±2.9%, p<0.01), suggesting a subclinical segmental systolic dysfunction. A combination of >-19.0 dB basal anteroseptal cIBS or >-18.0% basal anteroseptal longitudinal strain had a sensitivity of 98% and a specificity of 72% in differentiating Mut+/Phen- group from controls. Conclusion: The use of cIBS and segmental longitudinal strain can differentiate HCM Mut+/Phen- patients from controls with important clinical implications for the family screening and follow-up of these patients. © 2012 Yiu et al. | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Unpaywall 20191101 | |
dc.subject | angiotensin receptor antagonist | |
dc.subject | beta adrenergic receptor blocking agent | |
dc.subject | calcium channel blocking agent | |
dc.subject | dipeptidyl carboxypeptidase inhibitor | |
dc.subject | diuretic agent | |
dc.subject | myosin binding protein C | |
dc.subject | adult | |
dc.subject | article | |
dc.subject | calibration | |
dc.subject | cardiovascular risk | |
dc.subject | clinical article | |
dc.subject | controlled study | |
dc.subject | coronary artery disease | |
dc.subject | diabetes mellitus | |
dc.subject | electrocardiogram | |
dc.subject | female | |
dc.subject | gene mutation | |
dc.subject | heart ejection fraction | |
dc.subject | heart infarction | |
dc.subject | heart left ventricle | |
dc.subject | heart muscle | |
dc.subject | heart muscle revascularization | |
dc.subject | heart ventricle wall motion | |
dc.subject | heterozygote detection | |
dc.subject | human | |
dc.subject | hyperlipidemia | |
dc.subject | hypertension | |
dc.subject | hypertrophic cardiomyopathy | |
dc.subject | kidney dysfunction | |
dc.subject | male | |
dc.subject | phenotype | |
dc.subject | protein expression | |
dc.subject | reproducibility | |
dc.subject | sensitivity and specificity | |
dc.subject | smoking | |
dc.subject | systolic dysfunction | |
dc.subject | echocardiography | |
dc.subject | echography | |
dc.subject | genetics | |
dc.subject | heterozygote | |
dc.subject | hypertrophic cardiomyopathy | |
dc.subject | middle aged | |
dc.subject | mutation | |
dc.subject | pathology | |
dc.subject | pathophysiology | |
dc.subject | physiology | |
dc.subject | prognosis | |
dc.subject | systole | |
dc.subject | Adult | |
dc.subject | Cardiomyopathy, Hypertrophic | |
dc.subject | Echocardiography | |
dc.subject | Female | |
dc.subject | Heterozygote | |
dc.subject | Humans | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Mutation | |
dc.subject | Myocardium | |
dc.subject | Phenotype | |
dc.subject | Prognosis | |
dc.subject | Reproducibility of Results | |
dc.subject | Systole | |
dc.type | Article | |
dc.contributor.department | DUKE-NUS MEDICAL SCHOOL | |
dc.description.doi | 10.1371/journal.pone.0036115 | |
dc.description.sourcetitle | PLoS ONE | |
dc.description.volume | 7 | |
dc.description.issue | 5 | |
dc.description.page | e36115 | |
dc.published.state | Published | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1371_journal_pone_0036115.pdf | 1.65 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License